Atlas Trials

One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis

Clinical trial NCT06367361 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06367361
Sponsor
Universidad Peruana Cayetano Heredia
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Fascioliasis
Start date
2026-08-15
Primary completion
2029-04-15
Enrollment
336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.